cbdMD, Inc. (NYSE:YCBD ) Q2 2025 Earnings Conference Call May 15, 2025 4:20 PM ET Company Participants Brad Whitford – Chief Accounting Officer Ronan Kennedy – Chief Executive Officer and Chief Financial Officer Conference Call Participants Tom McGovern – Maxim Group Adam Waldo – Lismore Partners Operator Good afternoon. Welcome to the cbdMD, Inc. Conference Call to discuss results for their Second Quarter Fiscal 2025 period ending March 25, 2025.
cbdMD, Inc. (NYSE:YCBD ) Q1 2025 Earnings Conference Call February 13, 2025 4:20 PM ET Company Participants Brad Whitford - Chief Accounting Officer Ronan Kennedy - Interim Chief Executive Officer and Chief Financial Officer Conference Call Participants Adam Waldo - Lismore Partners, LLC Thomas McGovern - Maxim Group Operator Good afternoon. Welcome to the cbdMD, Inc.'s December 31, 2024, First Fiscal Quarter of 2025 Earnings Call and Update.
cbdMD, Inc. (NYSE:YCBD ) Q3 2024 Earnings Conference Call August 14, 2024 4:20 PM ET Company Participants Brad Whitford - Chief Accounting Officer Ronan Kennedy - Chief Executive Officer & Chief Financial Officer Conference Call Participants Thomas McGovern - Maxim Group Operator Good afternoon. Welcome to cbdMD's, Inc. June 30, 2024 Third Fiscal 2024 Quarter and Earnings Call and Update.
| Specialty Retail Industry | Consumer Discretionary Sector | T. Ronan Kennedy CEO | AMEX Exchange | 12482W101 CUSIP |
| US Country | 42 Employees | - Last Dividend | 7 May 2025 Last Split | 29 Apr 2019 IPO Date |
cbdMD, Inc., a distinguished entity in the cannabis industry, specializes in the production and distribution of a wide array of cannabidiol (CBD) products. The company prides itself on its ownership and operation of prominent consumer hemp-based CBD brands, including cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Initially known as Level Brands, Inc., the organization underwent a rebranding to cbdMD, Inc. in May 2019, positioning itself more directly within the CBD market sphere. Based in Charlotte, North Carolina, cbdMD, Inc. strategically distributes its wellness products both online via e-commerce platforms and offline through select distributors, marketing partners, and brick and mortar retailers across the United States.
cbdMD Brand Products: The flagship cbdMD brand encompasses a diverse portfolio, featuring CBD tinctures, gummies, topicals, capsules, and drink mixes designed to cater to various wellness needs. These include aids for sleep, focus, and calming, tailored to enhance users' overall well-being and lifestyle.
Paw CBD: Recognizing the importance of pet health, cbdMD, Inc. extends its CBD expertise to the veterinarian-formulated Paw CBD line. This brand offers tinctures, chews, and topicals, all engineered to provide the health benefits of CBD to pets in a safe and effective manner.
ATRx Brand: Stepping into the burgeoning nootropic space, the ATRx brand by cbdMD, Inc. introduces a nootropic mushroom line. This innovative offering combines the holistic wellness properties of mushrooms with CBD, aiming to cater to consumers seeking cognitive enhancement and mental wellness solutions.
hempMD Brand: The hempMD brand represents the company's expansion into hemp-derived solutions, further broadening its product offerings. This line is designed to meet the growing demand for hemp-based wellness products, emphasizing purity, quality, and consumer trust.
cbdMD Botanicals: Catering to the skincare market, cbdMD Botanicals integrates the therapeutic properties of CBD into a range of skincare products. This line is dedicated to delivering natural, hemp-derived skincare solutions aimed at improving skin health and appearance.